Palisade Bio Files 8-K on Security Holder Vote
Ticker: PALI · Form: 8-K · Filed: Jul 8, 2024 · CIK: 1357459
| Field | Detail |
|---|---|
| Company | Palisade Bio, Inc. (PALI) |
| Form Type | 8-K |
| Filed Date | Jul 8, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Palisade Bio is calling a shareholder vote, details to follow.
AI Summary
On July 8, 2024, Palisade Bio, Inc. filed an 8-K report to announce the submission of matters to a vote of its security holders. The filing does not contain details about the specific matters to be voted on or any associated financial implications.
Why It Matters
This filing indicates that Palisade Bio is seeking approval from its shareholders on certain corporate actions, which could impact the company's future direction and governance.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose any new financial risks or significant operational changes.
Key Players & Entities
- PALISADE BIO, INC. (company) — Registrant
- July 8, 2024 (date) — Date of earliest event reported
FAQ
What specific matters will be submitted for a vote by Palisade Bio's security holders?
The filing does not specify the exact matters to be voted on, only that matters are being submitted for a vote.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on July 8, 2024.
What is the principal executive office address for Palisade Bio, Inc.?
The principal executive office is located at 7750 El Camino Real Suite 2A Carlsbad, California 92009.
What is the telephone number for Palisade Bio, Inc.?
The telephone number, including area code, is (858) 704-4900.
What is the SIC code for Palisade Bio, Inc.?
The Standard Industrial Classification code is 2836, for Biological Products (No Diagnostic Substances).
Filing Stats: 608 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-07-08 17:15:31
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share PALI Nasdaq Capital Mark
Filing Documents
- form8-k.htm (8-K) — 43KB
- 0001493152-24-026504.txt ( ) — 212KB
- pali-20240708.xsd (EX-101.SCH) — 3KB
- pali-20240708_lab.xml (EX-101.LAB) — 33KB
- pali-20240708_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 8, 2024 Palisade Bio, Inc. By: /s/ J.D. Finley J.D. Finley Chief Executive Officer